Immune Effector Mechanisms Implicated in Atherosclerosis: From Mice to Humans

By Peter Libby, A. Lichtman, G. Hansson. Immunity, 2013

657 citations recorded by the source corpus.

According to the traditional view, atherosclerosis results from a passive buildup of cholesterol in the artery wall. Yet, burgeoning evidence implicates inflammation and immune effector mechanisms in the pathogenesis of this disease. Both innate and adaptive immunity operate during atherogenesis and link many traditional risk factors to altered arterial functions. Inflammatory pathways have become targets in the quest for novel preventive and therapeutic strategies against cardiovascular disease, a growing contributor to morbidity and mortality worldwide. Here we review current experimental and clinical knowledge of the pathogenesis of atherosclerosis through an immunological lens and how host defense mechanisms essential for survival of the species actually contribute to this chronic disease but also present new opportunities for its mitigation.

Subfields: Epidemiology, Immunology, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/4de3d65bc962aac513b7d3ea251af2431049454c

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

  1. E. Latz

In Immunology

  1. A. Grebe
  2. E. Latz
  3. Florian Hoss

In Molecular Biology

  1. A. Grebe
  2. E. Latz
  3. Florian Hoss

Citations in the corpus